iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
61 hedge funds and large institutions have $61.8M invested in iShares Genomics Immunology and Healthcare ETF in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.79% less ownership
Funds ownership: 41.71% → 40.92% (-0.79%)
Holders
61
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.25M | |
| 2 | +$920K | |
| 3 | +$685K | |
| 4 |
GS
GTS Securities
New York
|
+$676K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$408K |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.37M | |
| 3 | -$1.08M | |
| 4 |
OC
Opal Capital
Boca Raton,
Florida
|
-$604K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$331K |
